Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat vs Darbepoetin alfa in Incident Dialysis (ASCEND-ID)
NCT03029208Phase 3Completed
- Sponsor
- GSK
- Start
- May 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of daprodustat in anemia, sponsored by GSK. Started May 2017; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03029208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029208.